Request for Covid-19 Impact Assessment of this Report

Take Action
Diagnostic and Biotech

Europe Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country

  • THE3207048
  • 188 Pages
  • April 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Europe genomics market is expected to reach US$ 10.1 Bn in 2025 from US$ 4.6 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025.

The growth of the genomics market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, nonexistence of skilled professionals and risks associated with genetic data are likely to pose a negative impact on the market growth. On the other hand, an extensive use of genomics for medical applications is likely to have a positive impact on the growth of the Europe genomics market in the coming years.

Advancement in the field of genomics has rapidly increasing. Many industry players have come up with innovative technique and ideas in last few years. The techniques such as cloning, gene sequencing, genome engineering has results into the generation of genetically modified organisms. The technological advancement as headed emergence of the New Bioeconomy, which is the replacement of petrochemical-based manufacturing and fermentation-based manufacturing products. In addition, the investments from public and private investors are rising for the gene editing. The rise in the investment are enabling technological developments and standard biological parts. For instance, in October 2018, Roche launched three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumours, complement Roche’s NGS ctDNA kits for oncology research. For instance, in September 2016, GenScript launched a new CRISPR Synthetic RNA Service Technology that offers fast DNA editing with fewer off-target effects. Advancement in genomics have added various solution for most of the industries such as, pharmaceutical and agriculture. These technological advancement are likely to grow the market in near future. Thus, technological advancements are expected to bring about innovative treatments in the market thereby driving the Europe genome editing market growth over the forecast years.

In 2017, the sequencing segment held a largest market share of 38.1% of the genomics market, by technology. This segment is also expected to dominate the market in 2025 owing to higher acceptance of the sequencing procedures for the genomics. Furthermore, the microarray segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

In 2017, the consumables segment held a largest market share of 46.5% of the genomics market, by product & service. This segment is also expected to dominate the market in 2025 as the consumables provides accuracy, speed, support across the globe for the systems used in the gene synthesis and genomics. Furthermore, the services segment is anticipated to witness the fastest growth rate during the forecast period, 2018 to 2025.

By application, the diagnostics segment is anticipated to grow at a CAGR of 11.2% during the forecast period. The diagnostics helps benefit the human to avoid the inheritance of the diseases in their children and diagnostics provides clarity for more concise treatment. Moreover, the segment held the largest market share of 32.2% for the application segment in the genomics market and is likely to dominate the market in coming forecast period.

In 2017, the research centers segment held a largest market share of the genomics market, by end user. This segment is also expected to dominate the market in 2025. However, the hospitals & clinics segment is anticipated to witness the fastest growth rate of 11.1% during the forecast period, 2017 to 2025. This higher growth rate of the segment owing to the providing the references for further researches are likely to propel the growth of the research centers segment in the coming future.

Some of the major primary and secondary sources for genomics included in the report are, Association for Responsible Research and Innovation in Genomics (ARRIGE), Biotechnology Industry Research Assistance Council (BIRAC), Defense Advanced Research Projects Agency (DARPA), Department of Biotechnology (DBT), European Research Area (ERA), and among others.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. EUROPE GENOMICS MARKET - KEY TAKEAWAYS

PART 3. EUROPE GENOMICS MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Europe Genomics Market - By Technology

3.2.2 Europe Genomics Market - By Product & Services

3.2.3 Europe Genomics Market - By Application

3.2.4 Europe Genomics Market - By End User

3.2.5 Europe Genomics Market - By Country

3.3 PEST ANALYSIS

PART 4. EUROPE GENOMICS MARKET-KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Rise in the Advancements For Genome Editing Technologies

4.1.2 Technological Developments in Genomics

4.2 KEY MARKET RESTRAINTS

4.2.1 Nonexistence of Skilled Professionals

4.2.2 Risks Associated With Genetic Data

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Extensive Use of Genomics for Medical Applications

4.4 FUTURE TRENDS

4.4.1 Usage of Gene Synthesis in Personalized Medicine

4.5 IMPACT ANALYSIS

PART 5. GENOMICS MARKET - EUROPE ANALYSIS

5.1 EUROPE GENOMICS MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING/ MARKET SHARE

5.3 PERFORMANCE OF KEY PLAYERS

5.3.1 Thermo Fisher Scientific Inc.

5.3.2 Illumina, Inc.

5.4 EXPERT OPINIONS

PART 6. EUROPE GENOMICS MARKET ANALYSIS - BY TECHNOLOGY

6.1 OVERVIEW

6.2 EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

6.3 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

6.4 SEQUENCING MARKET

6.4.1 Overview

6.4.2 Europe Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 MICROARRAY MARKET

6.5.1 Overview

6.5.2 Europe Microarray Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 POLYMERASE CHAIN REACTION (PCR) MARKET

6.6.1 Overview

6.6.2 Europe Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET

6.7.1 Overview

6.7.2 Europe Nucleic Acid Extraction and Purification Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 OTHERS MARKET

6.8.1 Overview

6.8.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. EUROPE GENOMICS MARKET ANALYSIS - BY PRODUCT & SERVICE

7.1 OVERVIEW

7.2 EUROPE GENOMICS MARKET, BY PRODUCT & SERVICE, 2017 & 2025 (%)

7.3 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

7.4 INSTRUMENTS/SYSTEMS MARKET

7.4.1 Overview

7.4.2 Europe Instruments/Systems Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CONSUMABLES MARKET

7.5.1 Overview

7.5.2 Europe Consumables Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 SERVICES MARKET

7.6.1 Overview

7.6.2 Europe Services Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. EUROPE GENOMICS MARKET ANALYSIS - BY APPLICATION

8.1 OVERVIEW

8.2 EUROPE GENOMICS MARKET, BY APPLICATION, 2017 & 2025 (%)

8.3 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

8.4 DIAGNOSTICS MARKET

8.4.1 Overview

8.4.2 Europe Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 DRUG DISCOVERY & DEVELOPMENT MARKET

8.5.1 Overview

8.5.2 Europe Drug Discovery & Development Market Revenue and Forecasts to 2025 (US$ Mn)

8.6 PRECISION/PERSONALIZED MEDICINE MARKET

8.6.1 Overview

8.6.2 Europe Precision/Personalized Medicine Market Revenue and Forecasts to 2025 (US$ Mn)

8.7 AGRICULTURE & ANIMAL RESEARCH MARKET

8.7.1 Overview

8.7.2 Europe Agriculture & Animal Research Market Revenue and Forecasts to 2025 (US$ Mn)

8.8 OTHERS MARKET

8.8.1 Overview

8.8.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. EUROPE GENOMICS MARKET ANALYSIS - BY END USER

9.1 OVERVIEW

9.2 EUROPE GENOMICS MARKET, BY END USER, 2017 & 2025 (%)

9.3 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

9.4 RESEARCH CENTERS MARKET

9.4.1 Overview

9.4.2 Europe Research Centers Market Revenue and Forecasts to 2025 (US$ Mn)

9.5 HOSPITALS & CLINICS MARKET

9.5.1 Overview

9.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2025 (US$ Mn)

9.6 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET

9.6.1 Overview

9.6.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)

9.7 OTHERS MARKET

9.7.1 Overview

9.7.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 10. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025

10.1 OVERVIEW

10.2 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

10.3 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

10.4 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

10.5 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

10.6 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

10.7 EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

10.8 GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

10.8.1 Germany Genomics Market Revenue and Forecasts to 2025 (US$ Mn)

10.8.2 Germany Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

10.8.3 Germany Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)

10.8.4 Germany Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.8.5 Germany Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)

10.9 UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

10.9.1 UK Genomics market Revenue and Forecasts to 2025 (US$ Mn)

10.9.2 UK Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

10.9.3 UK Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)

10.9.4 UK Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.9.5 UK Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)

10.10 FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

10.10.1 France Genomics Market Revenue and Forecasts to 2025 (US$ Mn)

10.10.2 France Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

10.10.3 France Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)

10.10.4 France Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)

10.10.5 France Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)

PART 11. GENOMICS MARKET -INDUSTRY LANDSCAPE

11.1 OVERVIEW

11.2 GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018

11.3 ORGANIC GROWTH STRATEGIES

11.3.1 Overview

11.3.2 Product Launch

11.3.3 Approvals

11.3.4 Expansion

11.3.5 Product Expansion

11.3.6 Others

11.4 INORGANIC GROWTH STRATEGIES

11.4.1 Overview

11.4.2 Partnership

11.4.3 Acquisition

11.4.4 Collaboration

11.4.5 Agreement

PART 12. GENOMICS MARKET -KEY COMPANY PROFILES

12.1 BEIJING GENOMICS INSTITUTE

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Financial Overview

12.1.4 Product & Services Portfolio

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F. HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Financial Overview

12.2.4 Product Portfolio

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 DANAHER

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Financial Overview

12.3.4 Product Portfolio

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 BIO-RAD LABORATORIES, INC.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Financial Overview

12.4.4 Product Portfolio

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 GENERAL ELECTRIC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Financial Overview

12.5.4 Product Portfolio

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 THERMOFISHER SCIENTIFIC INC.

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Financial Overview

12.6.4 Product Portfolio

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AGILENT TECHNOLOGIES

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Financial Overview

12.7.4 Product Portfolio

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 ILLUMINA, INC.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Financial Overview

12.8.4 Product Portfolio

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 EUROFINS SCIENTIFIC

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Financial Overview

12.9.4 Product/ Services Portfolio

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 QIAGEN

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 Swot Analysis

12.10.6 Key Developments

PART 13. APPENDIX

13.1 ABOUT THE INSIGHT PARTNERS

13.2 GLOSSARY OF TERMS

13.3 METHODOLOGY

13.3.1 Coverage

13.3.2 Secondary Research

13.3.3 Primary Research

LIST OF TABLES

TABLE 1. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 2. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

TABLE 3. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 4. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 5. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 6. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

TABLE 7. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 8. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 9. GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 10. GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

TABLE 11. GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 12. GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 13. UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 14. UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

TABLE 15. UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 16. UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 17. FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 18. FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT & SERVICE (US$ MN)

TABLE 19. FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 20. FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 21. RECENT PRODUCT LAUNCH IN THE GENOMICS MARKET

TABLE 22. PRODUCT ENHANCEMENT & SOFTWARE UPGRADATION IN THE GENOMICS MARKET

TABLE 23. EXPANSION ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET

TABLE 24. PRODUCT EXPANSION ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET

TABLE 25. OTHERS ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET

TABLE 26. RECENT PARTNERSHIP IN THE GENOMICS MARKET

TABLE 27. RECENT ACQUISITION IN THE GENOMICS MARKET

TABLE 28. RECENT COLLABORATION IN THE GENOMICS MARKET

TABLE 29. RECENT AGREEMENT IN THE GENOMICS MARKET

TABLE 30. GLOSSARY OF TERMS, GENOMICS MARKET

LIST OF FIGURES

FIGURE 1. GERMANY GENOMICS MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025

FIGURE 2. EUROPE GENOMICS MARKET BY TECHNOLOGY, MARKET SHARE (%), 2017

FIGURE 3. EUROPE GENOMICS MARKET BY PRODUCT & SERVICE, MARKET SHARE (%), 2017

FIGURE 4. EUROPE GENOMICS MARKET BY APPLICATION, MARKET SHARE (%), 2017

FIGURE 5. EUROPE GENOMICS MARKET BY END USER, MARKET SHARE (%), 2017

FIGURE 6. GENOMICS MARKET SEGMENTATION

FIGURE 7. EUROPE PEST ANALYSIS

FIGURE 8. GENOMICS MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 9. EUROPE GENOMICS MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 10. EUROPE GENOMICS MARKET - KEY MARKET PLAYERS

FIGURE 11. EUROPE GENOMICS MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

FIGURE 12. EUROPE SEQUENCING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. EUROPE MICROARRAY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. EUROPE NUCLEIC ACID EXTRACTION AND PURIFICATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 16. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. EUROPE GENOMICS MARKET BY PRODUCT & SERVICE, 2017 & 2025 (%)

FIGURE 18. EUROPE INSTRUMENTS/SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. EUROPE CONSUMABLES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. EUROPE SERVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. EUROPE GENOMICS MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 22. EUROPE DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. EUROPE DRUG DISCOVERY & DEVELOPMENT MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. EUROPE PRECISION/PERSONALIZED MEDICINE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 25. EUROPE AGRICULTURE & ANIMAL RESEARCH MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 26. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. EUROPE GENOMICS MARKET BY END USER, 2017 & 2025 (%)

FIGURE 28. EUROPE RESEARCH CENTERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. EUROPE HOSPITALS & CLINICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 30. EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 31. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 32. EUROPE GENOMICS MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)

FIGURE 33. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 34. EUROPE GENOMICS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 35. GERMANY GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 36. UK GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 37. FRANCE GENOMICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 38. GROWTH STRATEGIES IN THE GENOMICS DEVICES MARKET, 2015-2018

FIGURE 39. ORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018

FIGURE 40. INORGANIC GROWTH STRATEGIES IN THE GENOMICS MARKET, 2015-2018

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
View Details
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research